Financial Summary (All financials)
| In millions, except per share items | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Mar-25-03 | Dec-31-02 | Mar-25-02 |
| Revenues | 2,136.2 | 2,035.3 | 2,055.0 | 1,984.3 | 1,846.0 | 1,846.0 | 1,705.0 | 1,705.0 |
| Revenue growth | 5.0% | -1.0% | 3.6% | 7.5% | 8.3% | 8.3% | -4.0% | -4.0% |
| Cost of goods sold | 1,405.7 | 1,343.4 | 1,391.1 | 1,291.6 | 1,166.9 | 1,167.0 | 1,040.0 | 1,040.0 |
| Gross profit | 730.5 | 691.9 | 663.9 | 692.7 | 679.1 | 679.0 | 665.0 | 665.0 |
| Gross margin | 34.2% | 34.0% | 32.3% | 34.9% | 36.8% | 36.8% | 39.0% | 39.0% |
| Selling, general and administrative | 376.9 | 372.2 | 382.5 | 382.1 | 359.9 | 360.0 | 348.0 | 348.0 |
| Research and development | 43.8 | 38.8 | 40.8 | 42.7 | 38.7 | 39.0 | 42.0 | 42.0 |
| EBITA | 304.0 | 276.4 | 165.2 | 285.3 | 263.8 | 282.0 | 247.0 | 247.0 |
| EBITA margin | 14.2% | 13.6% | 8.0% | 14.4% | 14.3% | 15.3% | 14.5% | 14.5% |
| Amortization of intangibles | 39.7 | 24.6 | 25.4 | 26.3 | 8.0 | 27.0 | 29.0 | 29.0 |
| EBIT | 264.3 | 251.8 | 139.8 | 259.0 | 255.8 | 255.0 | 218.0 | 218.0 |
| EBIT margin | 12.4% | 12.4% | 6.8% | 13.1% | 13.9% | 13.8% | 12.8% | 12.8% |
| Pre-tax income | 199.2 | 430.9 | -37.3 | 31.9 | 95.8 | 95.0 | -52.0 | -52.0 |
| Income taxes | 20.3 | 192.2 | 3.8 | 3.8 | 21.3 | 21.0 | -3.0 | -3.0 |
| Tax rate | 10.2% | 44.6% | | 11.9% | 22.2% | 22.1% | 5.8% | 5.8% |
| Earnings from continuing ops | 178.9 | 238.7 | -41.1 | 28.1 | 74.2 | 4.0 | -196.0 | -196.0 |
| Earnings from discontinued ops | 8.0 | 47.0 | -6.5 | -2.6 | 4.5 | 0.0 | 0.0 | 0.0 |
| Net income | 178.9 | 238.7 | -41.1 | 28.1 | 45.4 | 4.0 | -196.0 | -196.0 |
| Net margin | 8.4% | 11.7% | -2.0% | 1.4% | 2.5% | 0.2% | -11.5% | -11.5% |
| |
| Diluted EPS | $1.55 | $2.14 | ($0.38) | $0.26 | $0.69 | $37.07 | ($1,849.06) | ($1,849.06) |
| Shares outstanding (diluted) | 115.1 | 111.3 | 108.7 | 109.0 | 107.2 | 0.1 | 0.1 | 0.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|